Treatment Action Group
Budget
€3,410,699
EP Access
0
accredited persons
Staff
2
0.35 FTE
EU Grants
None
Mission & Goals
Treatment Action Group (TAG) is an independent, activist, and community-based research and policy think tank fighting to end HIV, tuberculosis (TB), and hepatitis C virus (HCV). TAG envisions the end of the HIV, TB, and HCV pandemics with the discovery, development, and worldwide dissemination of safe and effective diagnostics, preventives, and cures through public health structures that end systemic harms and promote human rights, and that are developed by the diverse communities most affected by these conditions. TAG catalyzes open collective action by affected communities, scientists, and policymakers to ensure that all people living with or impacted by HIV, TB, or HCV — especially communities of color and other marginalized communities experiencing inequities — receive life-saving prevention, diagnosis, treatment, care, and information.
EU Legislative Interests
EU Global Health Strategy; Horizon Europe R&I policies; EU policies on antimicrobial resistance, pandemic preparedness, and other health research.
Communication Activities
TAG publishes an annual report on global funding for tuberculosis research and development (R&D), which contains analysis of and information on EU funding for TB R&D (https://www.treatmentactiongroup.org/resources/tbrd-report/). TAG publishes an an annual report tracking the clinical development pipelines of new vaccines, diagnostics, and treatments for TB, HIV, and viral hepatitis, some of which are funded by EU institutions (https://www.treatmentactiongroup.org/resources/pipeline-report/2024-pipeline-report/).
Interests Represented
Does not represent commercial interests
Member Of
TAG is a member of the Washington, D.C.-based Global Health Technologies Coalition (https://www.ghtcoalition.org/our-members). TAG is also a member of the Stop TB Partnership, hosted by UNOPS and based in Geneva, Switzerland (https://stoptb.org/partners/). We belong to a network of organizations working on EU global health policy coordinated by Deutsche Stiftung Weltbevölkerung (DSW) (https://www.dsw.org/en/global-health/).
Organisation Members
Treatment Action Group participates in an informal advocacy coalition advancing research on new TB vaccines called TB Vax ARM (https://newtbvaccines.org/take-action/) that interfaces with EU institutions on policy issues on issues related to global health research and development.
Additional Information
Please note that the estimate of annual costs related to activities covered by the Register is estimated to be very low as Treatment Action Group (TAG) is a USA-based organization that engages with the EU on narrow, discrete topics and not as a matter of our primary mission. Our engagement is limited to EU policies and programmes related to global health research, specifically within the sub-field of infectious diseases and primarily focused on tuberculosis (TB). Estimates of staff time reflect reasonable estimates of effort given to these activities and to supervising the work of a Brussels-based consultant, Karen Hoehn of Bonstar Consulting, with whom TAG has a contractual relationship to outsource relevant representation activities. Our contract with Karen Hoehn totals USD $25,000 (~EUR 22,100) for the period January 2025 through March 2026, subject to renewal at similar level of effort.
Commissioner Meetings
No recorded meetings with EU commissioners.